Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr592 Inhibitors

Olr592 inhibitors represent a class of chemical compounds that specifically target and inhibit the activity of the Olr592 protein, a member of the olfactory receptor family. These receptors are typically involved in the detection of odorants and are part of the larger G protein-coupled receptor (GPCR) superfamily. The inhibition of Olr592 activity provides a unique insight into the molecular mechanisms governing olfactory signal transduction. Structurally, Olr592 inhibitors are designed to bind with high affinity to the active site of the Olr592 receptor, preventing its interaction with natural ligands. This interaction often involves a combination of hydrogen bonding, van der Waals forces, and hydrophobic interactions, ensuring that the inhibitor remains tightly bound and effectively blocks receptor activity. The molecular diversity of Olr592 inhibitors includes various scaffolds, such as heterocyclic compounds, peptidomimetics, and small organic molecules, each tailored to optimize binding affinity and specificity.

The study of Olr592 inhibitors extends into understanding the broader implications of olfactory receptor modulation. Researchers employ these inhibitors as molecular tools to dissect the signaling pathways activated by olfactory receptors and to map out the structural and functional landscape of these proteins. The inhibition of Olr592 can alter downstream signaling events, providing critical information on how olfactory signals are processed and integrated within the sensory system. Advanced techniques, such as X-ray crystallography and cryo-electron microscopy, are often used to elucidate the three-dimensional structures of Olr592-inhibitor complexes, revealing detailed interaction patterns and guiding the design of more potent and selective inhibitors. Additionally, computational modeling and molecular dynamics simulations contribute to understanding the dynamic behavior of these complexes in a cellular context. Through these multidisciplinary approaches, Olr592 inhibitors serve as valuable tools in the fundamental research of olfactory biology, enhancing our comprehension of the intricate molecular machinery underlying sensory perception.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Afatinib-d4

850140-72-6 (unlabeled)sc-481821
10 mg
$4665.00
(0)

Inhibits EGFR, HER2, and HER4, potentially affecting proteins in these signaling pathways.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits MET, VEGFR, and RET, potentially affecting proteins in multiple signaling pathways.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

BRAF inhibitor, potentially affecting proteins involved in the MAPK/ERK pathway.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits Bruton's tyrosine kinase, potentially affecting proteins in B-cell receptor signaling.

CAL-101

870281-82-6sc-364453
10 mg
$193.00
4
(1)

Inhibits PI3K delta, potentially altering proteins involved in cell signaling and survival.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits BCR-ABL tyrosine kinase, potentially affecting proteins in leukemia-associated pathways.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Inhibits BCR-ABL and c-KIT tyrosine kinases, potentially affecting proteins in associated signaling pathways.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits VEGF receptors, potentially affecting proteins involved in angiogenesis and tumor growth.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, potentially influencing apoptosis-related proteins.